Details
Stereochemistry | ACHIRAL |
Molecular Formula | C29H34N2O2 |
Molecular Weight | 442.5925 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C(CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)CC4(OCCO4)C5=CC=CC=C5
InChI
InChIKey=LRMJAFKKJLRDLE-UHFFFAOYSA-N
InChI=1S/C29H34N2O2/c1-4-11-25(12-5-1)28(26-13-6-2-7-14-26)31-21-19-30(20-22-31)18-10-17-29(32-23-24-33-29)27-15-8-3-9-16-27/h1-9,11-16,28H,10,17-24H2
Molecular Formula | C29H34N2O2 |
Molecular Weight | 442.5925 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Dotarizine was developed as antimigraineur. Dotarizine inhibited the 5-HT2A response in a concentration-dependent manner. The mechanism of blockade by dotarizine of cerebral vessels contractility has three components: (i) presynaptic inhibition of noradrenaline release; (ii) blockade of postsynaptic vascular 5-HT receptors; (iii) blockade of Ca(2+)entry into the vascular smooth muscle cell cytosol. The compound does not affect the vascular receptors for noradrenaline, angiotensin II or prostaglandin F(2alpha). Dotarizine had a pronounced protective effect against electric seizures.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. | 2005 Sep 27 |
|
Pain and psychiatry: a critical analysis and pharmacological review. | 2006 Nov 6 |
|
Optimizing prophylactic treatment of migraine: Subtypes and patient matching. | 2008 Oct |
|
Effect of buspirone on thermal sensory and pain thresholds in human volunteers. | 2009 May 29 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11140170
Repeated doses of 50 and 10 mg/kg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:44:29 GMT 2023
by
admin
on
Fri Dec 15 15:44:29 GMT 2023
|
Record UNII |
IO7663S6D3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C333
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
||
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
84625-59-2
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
DB06446
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
55285
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
SUB06378MIG
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
138033
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
DOTARIZINE
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
5386
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106316
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
IO7663S6D3
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
C77827
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
100000080769
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
DTXSID60233630
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
C083946
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | |||
|
m4747
Created by
admin on Fri Dec 15 15:44:29 GMT 2023 , Edited by admin on Fri Dec 15 15:44:29 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||